Hematological changes in patients affected by COVID-19

Authors

DOI:

https://doi.org/10.33448/rsd-v10i17.24135

Keywords:

Hematopoietic system; SARS-CoV-2; COVID-19.

Abstract

This work focused on evaluating the main changes caused in the blood system in patients with COVID-19. This is a systematic literature review based on searches in the PubMed and Science Direct databases, using specific descriptors. Only studies in their full versions, with no language restrictions and published in the time frame from December 2019 to November 2020, were included. SARS-CoV-2 may be related to several alterations in various organs and systems, including the hematopoietic system. The various hematological alterations caused by the infection resulting from the new coronavirus are of paramount importance given the current health problem, considering that such alterations may be directly related to the poor prognosis and even the death of many patients. The SARS-CoV-2 is the seventh in the family to be described as being associated with the disease in humans, having great ease of interpersonal transmission and, therefore, it can spread quickly. As for symptoms, COVID-19 is characterized as an infection with a broad symptomatological spectrum, which can range from a completely asymptomatic condition to severe clinical conditions with systemic symptoms and in multiple organs. There are several changes in hematopoietic tissue, with emphasis on disturbances in the coagulation cascade, such as the incidence of thromboembolic events, increase in Prothrombin Time and Activated Partial Thromboplastin Time, followed by a decreased platelet count, exacerbated increase in D-dimer, in addition to the low clotting activity of fibrinogen.

References

Boccia, M., Aronne, L., Celia, B., Mazzeo, G., Ceparano, M., D'Agnano, V., ... & Perrotta, F. (2020). COVID-19 and coagulative axis: review of emerging aspects in a novel disease. Monaldi Archives for Chest Disease, 90(2).

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., ... & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet, 395(10223), 507-513.

Colling, M. E., & Kanthi, Y. (2020). <? covid19?> COVID–19-associated coagulopathy: An exploration of mechanisms. Vascular Medicine, 25(5), 471-478.

Deng, Y., Liu, W., Liu, K., Fang, Y. Y., Shang, J., Zhou, L., ... & Liu, H. G. (2020). Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chinese medical journal, 133(11), 1261.

Fathi, N., & Rezaei, N. (2020). Lymphopenia in COVID‐19: Therapeutic opportunities. Cell biology international, 44(9), 1792-1797.

Frater, J. L., Zini, G., d’Onofrio, G., & Rogers, H. J. (2020). COVID‐19 and the clinical hematology laboratory. International journal of laboratory hematology, 42, 11-18.

Giannis, D., Ziogas, I. A., & Gianni, P. (2020). Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology, 127, 104362.

Grobler, C., Maphumulo, S. C., Grobbelaar, L. M., Bredenkamp, J. C., Laubscher, G. J., Lourens, P. J., ... & Pretorius, E. (2020). Covid-19: The rollercoaster of fibrin (ogen), d-dimer, von willebrand factor, p-selectin and their interactions with endothelial cells, platelets and erythrocytes. International journal of molecular sciences, 21(14), 5168.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.

Iba, T., Levy, J. H., Levi, M., Connors, J. M., & Thachil, J. (2020). Coagulopathy of coronavirus disease 2019. Critical care medicine.

Kasinathan, G., Sathar, J. Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: a review. Annals of Medicine and Surgery, 2020.

Langer, F., Kluge, S., Klamroth, R., & Oldenburg, J. (2020). Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis. Hämostaseologie, 40(03), 264-269.

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., ... & Feng, Z. (2020a). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England journal of medicine.

Li, Q., Cao, Y., Chen, L., Wu, D., Yu, J., Wang, H., ... & Hu, Y. (2020b). Hematological features of persons with COVID-19. Leukemia, 34(8), 2163-2172.

Liao, D., Zhou, F., Luo, L., Xu, M., Wang, H., Xia, J., ... & Hu, Y. (2020). Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. The Lancet Haematology, 7(9), e671-e678.

Linares-Espinós, E., Hernández, V., Domínguez-Escrig, J. L., Fernández-Pello, S., Hevia, V., Mayor, J.,... & Ribal, M. J. (2018). Methodology of a systematic review. Metodología de una revisión sistemática. Actas urologicas espanolas, 42(8), 499–506.

Lippi, G., Plebani, M., & Henry, B. M. (2020). Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica chimica acta, 506, 145-148.

Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., ... & Force, T. (2020). Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis research, 191, 9-14.

Ludwig, S., & Zarbock, A. (2020). Coronaviruses and SARS-CoV-2: a brief overview. Anesthesia and analgesia.

Mucha, S. R. et al. (2020). Coagulopathy in COVID-19: Manifestations and management. Cleveland Clinic journal of medicine, 87(8), 461.

National Health Commission. (2020). Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7). Chinese Medical Journal (Engl), 133(9), 1087-1095.

Our World in Data. Coronavirus Pandemic (COVID-19) – the data. https://ourworldindata.org/coronavirus-data.

Pang, J., Wang, M. X., Ang, I. Y. H., Tan, S. H. X., Lewis, R. F., Chen, J. I. P., ... & Hsu, L. Y. (2020). Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. Journal of clinical medicine, 9(3), 623.

Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V., ... & Tripodi, A. (2020). Hypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. Journal of Thrombosis and Haemostasis, 18(7), 1738-1742.

Pourbagheri-Sigaroodi, A., Bashash, D., Fateh, F., & Abolghasemi, H. (2020). Laboratory findings in COVID-19 diagnosis and prognosis. Clinica Chimica Acta; International Journal of Clinical Chemistry, 510, 475.

Qi, J., Zhou, Y., Hua, J., Zhang, L., Bian, J., Liu, B., ... & Jin, S. (2021). The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to SARS-CoV-2 infection. International Journal of Environmental Research and Public Health, 18(1), 284.

Santos-Sánchez, N. F., & Salas-Coronado, R. (2020). Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19. Medwave, 20(8).

Terpos, E., Ntanasis‐Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., ... & Dimopoulos, M. A. (2020). Hematological findings and complications of COVID‐19. American journal of hematology, 95(7), 834-847.

Vinayagam, S., & Sattu, K. (2020). SARS-CoV-2 and coagulation disorders in different organs. Life Sciences, 118431.

Yang, X., Yu, Y., Xu, J., Shu, H., Liu, H., Wu, Y., ... & Shang, Y. (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 8(5), 475-481.

Yuan, X., Huang, W., Ye, B., Chen, C., Huang, R., Wu, F., ... & Hu, J. (2020). Changes of hematological and immunological parameters in COVID-19 patients. International journal of hematology, 112(4), 553-559.

Zhang, Y., Zeng, X., Jiao, Y., Li, Z., Liu, Q., Ye, J., & Yang, M. (2020a). Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thrombosis research, 193, 110-115.

Zhang, Z. L., Hou, Y. L., Li, D. T., & Li, F. Z. (2020b). Laboratory findings of COVID-19: a systematic review and meta-analysis. Scandinavian journal of clinical and laboratory investigation, 80(6), 441-447.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., ... & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 395(10229), 1054-1062.

Zhu, J., Ji, P., Pang, J., Zhong, Z., Li, H., He, C., ... & Zhao, C. (2020). Clinical characteristics of 3062 COVID‐19 patients: a meta‐analysis. Journal of medical virology, 92(10), 1902-1914.

Published

22/12/2021

How to Cite

COELHO, F. A. da R. .; CARMO, R. R. de S. .; SILVA, W. R. da .; SOUSA, J. P. A. de .; GUIMARÃES, A. C. de M. .; QUEIROZ, L. da S. .; NASCIMENTO, H. M. S. .; NUNES, T. A. de L. .; BRITO, V. dos S. .; LIRA, J. A. S. P. de .; GOMES, P. R. C. .; ALVES, E. H. P. .; SOUSA, J. M. S. de .; SANTOS, A. L. S. dos .; ARAUJO, P. M. de S. . Hematological changes in patients affected by COVID-19. Research, Society and Development, [S. l.], v. 10, n. 17, p. e117101724135, 2021. DOI: 10.33448/rsd-v10i17.24135. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/24135. Acesso em: 24 jan. 2022.

Issue

Section

Review Article